QUOTE(Archaic @ Feb 28 2008, 11:04 PM) [snapback]462201[/snapback]
Obviously there are no legitimate scientific studies which came up with androgenic/anabolic ratios.
For a large number of reasons not the least of which is it's impossible to quantify androgenicity (what number of pimples? how many times you got horny in a day? how much the strength gain gave you in bench press results, how many times you 'raged')...
Foolish to attempt to pass off these numbers as actual research, they were obviously dreamed up by a so-called enlightened juicer philosopher.

False. This is established terminology in endocrinology.
1) C. Kuhn, "Anabolic Steroids". Recent Progress in Hormone Research. 57(2002).
"Testosterone actions represent the combination of several activities. First, it binds to the androgen receptor to exert its androgenic activity. Second, it is 5a-reduced in some target tissues (including the male urogenital tract, skin, liver, and sebaceous glands) to dihydrotestosterone (DHT), which also acts on the androgen receptor. Finally, it can be aromatized to The latter two actions are highly undesirable in anabolic drugs, 5a reduction because it decreases the ratio of anabolic:androgenic activity and aromatization because of the feminizing side effects."
"To verify the anabolic effect of the treatments, the levator ani (LA) and ventral prostate (VP) weights were measured and the ratio of LA/VP was calculated as an estimate of the anabolic potency of the AAS compounds [14]. This ratio varied from 0.3 to 1.18 (Table 2), the greater value is indicative of a greater anabolic or myotropic activity relative to androgenic activity. Stanozolol, nandrolone, danazol, and methandrostenolone all had ratios close to 1, whereas the ratios for T and DHT were 0.4 and 0.3, receptively. There was no significant effect of treatment on body weights."
http://rphr.endojournals.org/cgi/reprint/57/1/411.pdf2) C. Rosselli. "The effect of anabolic–androgenic steroids on aromatase activity and androgen receptor binding in the rat preoptic area". Brain Research. 792.2 (1998).
"The androgenic:anabolic ratio of an androgen is an important consideration when determining the clinical usefulness of these compounds. Accordingly, compounds with a high ratio of androgenic to anabolic effects remain the drug of choice in androgen-replacement therapy to treat hypogonadism in males, whereas compounds with reduced androgenic:anabolic ratios have significant benefits in the treatment of other medical conditions, in which their primary clinical application is for their anabolic effects (e.g., anemia, osteoporosis, and to reverse protein loss following trauma, surgery or prolonged immobilization."
3) N. Evans. "Current Concept in Anabolic-Androgenic Steroids". American Journal of Sports Medicine. 32 (2004).
"Chemical modifications of testosterone have been useful pharmacologically to alter the relative anabolic-androgenic potency, slow the rate of inactivation, change the pattern of metabolism, or decrease the aromatization to estradiol.101 Most orally active AAS preparations are 17- alkylated derivatives of testosterone that are relatively resistant to hepatic degradation.7 Esterification of the 17-ß-hydroxyl group makes the molecule more soluble in lipid vehicles used for injection and, hence, slows the release of the injected steroid into the circulation. The common formulations of synthetic testosterone are shown in Table 1. All of the listed drugs possess both anabolic and androgenic activity; none are absolutely selective. Testosterone has an anabolic:androgenic ratio of 1, whereas the ratio for nandrolone is 10 and that for stanozolol is 30. However, all AASs are virilizing if administered for long enough, at high enough doses."